These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2091893)

  • 1. Immunological privilege in the eye: a review.
    Tompsett E; Abi-Hanna D; Wakefield D
    Curr Eye Res; 1990 Dec; 9(12):1141-5. PubMed ID: 2091893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.
    Streilein JW
    Eye (Lond); 1995; 9 ( Pt 2)():236-40. PubMed ID: 7556724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune privilege in the anterior chamber of the eye.
    Niederkorn JY
    Crit Rev Immunol; 2002; 22(1):13-46. PubMed ID: 12186187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of inflammation on ocular immune privilege.
    Mo JS; Wang W; Kaplan HJ
    Chem Immunol Allergy; 2007; 92():155-165. PubMed ID: 17264491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular immune privilege sites.
    Masli S; Vega JL
    Methods Mol Biol; 2011; 677():449-58. PubMed ID: 20941626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts.
    Streilein JW; Yamada J; Dana MR; Ksander BR
    Transplant Proc; 1999 May; 31(3):1472-5. PubMed ID: 10330973
    [No Abstract]   [Full Text] [Related]  

  • 7. Local production of IFN-gamma abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID.
    Geiger K; Sarvetnick N
    J Immunol; 1994 Dec; 153(11):5239-46. PubMed ID: 7525729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune privilege: keeping an eye on natural killer T cells.
    Hong S; Van Kaer L
    J Exp Med; 1999 Nov; 190(9):1197-200. PubMed ID: 10544192
    [No Abstract]   [Full Text] [Related]  

  • 9. Tissue barriers, immunosuppressive microenvironments, and privileged sites: the eye's point of view.
    Streilein JW
    Reg Immunol; 1993; 5(5):253-68. PubMed ID: 8148235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of ocular immune privilege in the year 2010: modifying the immune privilege of the eye.
    Hori J; Vega JL; Masli S
    Ocul Immunol Inflamm; 2010 Oct; 18(5):325-33. PubMed ID: 20849282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulatory mechanisms of the eye.
    Streilein JW; Wilbanks GA; Cousins SW
    J Neuroimmunol; 1992 Aug; 39(3):185-200. PubMed ID: 1644895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular immune privilege in the year 2010: ocular immune privilege and uveitis.
    Taylor AW; Kaplan HJ
    Ocul Immunol Inflamm; 2010 Dec; 18(6):488-92. PubMed ID: 21091058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capacity of simian virus 40 T antigen to induce self-tolerance but not immunological privilege in the anterior chamber of the eye.
    Ma D; Comerford S; Bellingham D; Sambrook J; Gething MJ; Alizadeh H; Anand R; Mellon J; Niederkorn JY
    Transplantation; 1994 Mar; 57(5):718-25. PubMed ID: 8140635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ocular immune privilege.
    Taylor AW
    Eye (Lond); 2009 Oct; 23(10):1885-9. PubMed ID: 19136922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular immune privilege and CTL tolerance.
    McKenna KC; Kapp JA
    Immunol Res; 2004; 29(1-3):103-12. PubMed ID: 15181274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune response and the eye. TCR alpha-chain related molecules regulate the systemic immunity to antigen presented in the eye.
    Griffith TS; Herndon JM; Lima J; Kahn M; Ferguson TA
    Int Immunol; 1995 Oct; 7(10):1617-25. PubMed ID: 8562507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood.
    Wilbanks GA; Streilein JW
    J Immunol; 1991 Apr; 146(8):2610-7. PubMed ID: 1707912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of ocular immune responses.
    Streilein JW
    Eye (Lond); 1997; 11 ( Pt 2)():171-5. PubMed ID: 9349408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapies based on principles of ocular immune privilege.
    Zhang-Hoover J; Stein-Streilein J
    Chem Immunol Allergy; 2007; 92():317-327. PubMed ID: 17264506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eye-derived cytokines and the immunosuppressive intraocular microenvironment: a review.
    Streilein JW; Wilbanks GA; Taylor A; Cousins S
    Curr Eye Res; 1992; 11 Suppl():41-7. PubMed ID: 1424750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.